Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

Treatment with esketamine combined with an SNRI is linked to fewer adverse outcomes than treatment with an SSRI alone.

However, at times when their depression and anxiety cannot be treated with those, it may be the time to switch to serotonin-norepinephrine reuptake inhibitor (SNRI). This is a common strategy that ...

The most common antidepressants for PTSD include: A review of multiple studies examined each SSRI or SNRI's effectiveness at reducing PTSD symptoms: Generally, SSRIs and SNRIs have similar ...

During the double-blind treatment phase, patients were randomly assigned to receive aticaprant 10mg or placebo once daily, in addition to current antidepressant SSRI/SNRI therapy, for 42 days.